HRA Pharma creates
innovative products
to fill therapeutic gaps
in reproductive health
and endocrinology.
- December 16, 2011
Paris, France
HRA Pharma's partner, Preglem, the wholly owned subsidiary of Gedeon Richter Plc., receives positive CHMP opinion for uterine fibroids treatment. - December 5, 2011
Paris, France & Budapest, Hungary
HRA Pharma grants Richter marketing rights for Esmya for China, Russia and other CIS republics